News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,853 Results
Type
Article (981)
Company Profile (12)
Press Release (25860)
Section
Business (14034)
Career Advice (21)
Deals (2245)
Drug Delivery (3)
Drug Development (2389)
Employer Resources (7)
FDA (314)
Job Trends (859)
News (17876)
Policy (841)
Tag
2027 Biotech Bay Standard (1)
Academia (96)
Accelerated approval (1)
Allergies (4)
Alliances (825)
ALS (3)
Alzheimer's disease (112)
Antibody-drug conjugate (ADC) (5)
Approvals (342)
Artificial intelligence (13)
Autoimmune disease (2)
Automation (2)
Bankruptcy (1)
Best Places to Work (854)
Biosimilars (2)
Biotechnology (11)
Bladder cancer (6)
Breast cancer (39)
Cancer (167)
Cardiovascular disease (18)
Career advice (20)
Career pathing (2)
Cell therapy (6)
Cervical cancer (2)
Clinical research (2218)
Collaboration (31)
Compensation (15)
Complete response letters (1)
COVID-19 (24)
C-suite (9)
Cystic fibrosis (6)
Data (212)
Depression (4)
Diabetes (9)
Diagnostics (303)
Diversity, equity & inclusion (4)
Drug discovery (6)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (12929)
Employer branding (1)
Employer resources (8)
Events (2832)
Executive appointments (6)
FDA (502)
Frontotemporal dementia (2)
Funding (34)
Gene editing (2)
Gene therapy (8)
GLP-1 (30)
Government (111)
Guidances (116)
Healthcare (856)
HIV (2)
IgA nephropathy (3)
Immunology and inflammation (5)
Indications (4)
Infectious disease (30)
Inflammatory bowel disease (10)
Influenza (2)
Intellectual property (9)
Interviews (9)
IPO (1755)
Job creations (33)
Job search strategy (11)
JPM (1)
Labor market (3)
Layoffs (9)
Leadership (1)
Legal (116)
Liver cancer (1)
Lung cancer (24)
Lymphoma (20)
Management (1)
Manufacturing (9)
MASH (7)
Medical device (757)
Medtech (759)
Mergers & acquisitions (517)
Metabolic disorders (28)
Multiple sclerosis (7)
Neurodegenerative disease (9)
Neuropsychiatric disorders (2)
Neuroscience (152)
NextGen: Class of 2026 (419)
Non-profit (131)
Obesity (10)
Opinion (1)
Ovarian cancer (13)
Pain (6)
Pancreatic cancer (4)
Parkinson's disease (13)
Patents (8)
Patient recruitment (7)
Peanut (1)
People (819)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (543)
Phase 2 (912)
Phase 3 (929)
Pipeline (429)
Postmarket research (55)
Preclinical (141)
Prostate cancer (6)
Radiopharmaceuticals (9)
Rare diseases (14)
Real estate (105)
Recruiting (3)
Regulatory (707)
Reports (3)
Research institute (87)
Schizophrenia (7)
Series A (4)
Series B (2)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (7)
Sponsored (3)
Startups (67)
Stomach cancer (1)
Vaccines (5)
Weight loss (4)
Women's health (5)
Date
Today (3)
Last 7 days (26)
Last 30 days (53)
Last 365 days (1234)
2026 (67)
2025 (1245)
2024 (1372)
2023 (1603)
2022 (2257)
2021 (2703)
2020 (2265)
2019 (5564)
2018 (1389)
2017 (1284)
2016 (841)
2015 (1325)
2014 (816)
2013 (447)
2012 (572)
2011 (520)
2010 (369)
Location
Africa (9)
Alabama (7)
Arizona (4)
Asia (1351)
Australia (102)
California (412)
Canada (102)
China (31)
Colorado (20)
Connecticut (14)
Delaware (19)
Europe (3079)
Florida (60)
Georgia (14)
Illinois (40)
India (1)
Indiana (36)
Iowa (1)
Japan (22)
Kansas (1)
Kentucky (4)
Louisiana (3)
Maine (8)
Maryland (38)
Massachusetts (282)
Michigan (22)
Minnesota (25)
Missouri (6)
Montana (3)
Nevada (3)
New Hampshire (4)
New Jersey (114)
New York (109)
North Carolina (75)
Northern California (247)
Ohio (13)
Pennsylvania (83)
South America (27)
South Carolina (1)
Southern California (124)
Tennessee (3)
Texas (64)
United States (1518)
Utah (16)
Virginia (4)
Washington State (40)
Wisconsin (2)
26,853 Results for "205".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Series A
Novo-Backed Crystalys Debuts With $205M to Tackle Gout
Already approved in Japan, China and other Asian countries, Crystalys’ dotinurad works to lower serum uric acid levels.
September 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
January 8, 2026
·
7 min read
Press Releases
Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance
January 7, 2026
·
10 min read
Press Releases
Crystalys Therapeutics Launches with $205M Series A Financing to Transform the Treatment of Gout
October 1, 2025
·
5 min read
Press Releases
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
October 2, 2025
·
6 min read
Press Releases
Eilean Therapeutics Presents First-in-Class MALT1 Degrader TE205 Demonstrating In Vivo Efficacy in Ulcerative Colitis at the 4th International Conference on Microbiology and Immunology
November 4, 2025
·
2 min read
Press Releases
Kairos Pharma Announces New Department of Defense Funding for Research of ENV205
February 19, 2025
·
4 min read
Press Releases
Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial
May 6, 2025
·
2 min read
Press Releases
Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in Frontline Metastatic Pancreatic Ductal Adenocarcinoma
May 23, 2025
·
11 min read
Biotech Bay
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
Spruce Biosciences, Inc. announced topline results from its CAHmelia-203 study of tildacerfont in adult classic congenital adrenal hyperplasia and its CAHptain-205 study of tildacerfont in pediatric classic CAH.
March 13, 2024
·
15 min read
1 of 2,686
Next
